Hanger Ventures, a subsidiary of Hanger, Inc., has invested in Bionic Power, a Canadian company developing active lower-body orthotic devices. These devices improve mobility for individuals with neuromuscular conditions like cerebral palsy and spina bifida.
Hanger Ventures’ investment will provide Bionic Power with financial support, clinical research expertise, and technical guidance. The collaboration aims to bring innovative orthotic solutions to the market that address unmet clinical needs and enhance the quality of life for patients with mobility challenges.
Gualtiero Guadagni, CEO of Bionic Power, expressed his excitement about the partnership, indicating that Hanger Ventures offers more than just capital and that their support will empower them to expand our business and make a significant impact on individuals who can benefit from our life-changing solutions.
Hanger Ventures is committed to advancing innovation in orthotics and prosthetics. This investment aligns with their mission to accelerate technology development and improve patient outcomes globally. For more information, visit
Source link: http://www.businesswire.com/news/home/20240718915859/en/Hanger-Ventures-Announces-Inaugural-Investment
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
